Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Eni ADR | E | Jan 15, 2025 | 28.86 | +1.73 |
Enlight Renewable Energy | ENLT | Jan 15, 2025 | 17.10 | +2.15 |
Enlightify | ENFY | Jan 15, 2025 | 0.88 | 0.00 |
Enlink Midstream LLC Unit | ENLC | Jan 15, 2025 | 15.05 | +0.53 |
Enliven Therapeutics | ELVN | Jan 15, 2025 | 22.66 | +10.75 |
Enlivex Therapeutics | ENLV | Jan 15, 2025 | 1.15 | +0.88 |
Ennis | EBF | Jan 15, 2025 | 20.73 | +1.02 |
Enova International | ENVA | Jan 15, 2025 | 105.68 | +4.13 |
Enovis | ENOV | Jan 15, 2025 | 45.72 | +2.17 |
Enovix | ENVX | Jan 15, 2025 | 10.78 | +2.08 |
Enphase Energy | ENPH | Jan 15, 2025 | 65.83 | +0.58 |
Enpro | NPO | Jan 15, 2025 | 168.35 | +1.00 |
Enservco | ENSV | Jan 15, 2025 | 0.03 | -8.68 |
Enstar Group | ESGR | Jan 15, 2025 | 326.31 | -0.06 |
Enstar Group Depository E Pref | ESGRO | Jan 15, 2025 | 20.43 | +0.99 |
Enstar Pref | ESGRP | Jan 15, 2025 | 20.29 | +0.90 |
Ensysce Biosciences | ENSC | Jan 15, 2025 | 7.16 | +6.07 |
Entegris | ENTG | Jan 15, 2025 | 101.93 | +2.44 |
Entera Bio | ENTX | Jan 15, 2025 | 2.28 | -3.39 |
Entergy | ETR | Jan 15, 2025 | 78.99 | +1.84 |
Entergy Texas A Pref | ETI- | Jan 15, 2025 | 23.70 | +1.54 |
Entergy Utility Enterprises | EMP | Jan 15, 2025 | 21.51 | +1.53 |
Entero Therapeutics | ENTO | Jan 15, 2025 | 0.56 | +1.17 |
Enterprise Bancorp | EBTC | Jan 15, 2025 | 40.41 | +3.11 |
Enterprise Financial Services | EFSC | Jan 15, 2025 | 57.77 | +2.12 |
Enterprise Financial Services A Pref | EFSCP | Jan 15, 2025 | 18.99 | +0.46 |
Enterprise Products Partners LP Unit | EPD | Jan 15, 2025 | 33.34 | -0.33 |
Entrada Therapeutics | TRDA | Jan 15, 2025 | 12.25 | -1.92 |
Entravision Communications | EVC | Jan 15, 2025 | 2.40 | -0.41 |
Envela | ELA | Jan 15, 2025 | 6.76 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.